Organizing
Committee
  Congress
Information
  Program   Participation   Sponsorship
& Exhibition
  Travel Information
Program
Invited Faculty
> Program > Invited Faculty

Carolyn ROCHESTER, United States / Associate Professor of Medicine, Medical Director, Yale Clinical COPD Center


Department of Internal Medicine: Section of Pulmonary, Critical Care and Sleep Medicine
Yale University School of Medicine and VA Connecticut Healthcare System


[Educational Background.
1975 Riverdale Country School, Bronx, NY
1979 A.B., Smith College, Cum Laude, Northampton, MA
1983 M.D., Columbia University College of Physicians and Surgeons, New York, NY

[Work Experience]
ACADEMIC APPOINTMENTS:

1991-1992
Associate Research Scientist
Section of Pulmonary and Critical Care
Yale University School of Medicine
New Haven, CT

1992-1999
Assistant Professor of Medicine
Section of Pulmonary and Critical Care
Department of Medicine
Yale University School of Medicine
New Haven, CT

1999-Present
Associate Professor of Medicine
Section of Pulmonary and Critical Care
Department of Medicine
Yale University School of Medicine
New Haven, CT

HOSPITAL APPOINTMENTS:

1991-Present
Attending Physician
VA Connecticut Healthcare System
West Haven, CT

1991-2004
Medical Director, Pulmonary Progressive Stepdown Unit
Yale-New Haven Medical Center
New Haven, CT

1993-2000
Assistant Medical Director, Respiratory Care
Yale-New Haven Medical Center
New Haven, CT

1995-2000
Medical Director, Pulmonary Rehabilitation Program and Medical Rehabilitation Division
Gaylord Hospital
Wallingford, CT

1997-1998
Associate Director, Medical Intensive Care Unit
Yale-New Haven Hospital
New Haven, CT

2000-Present
Medical Director, Newington VAMC Pulmonary Clinics and Pulmonary Function Laboratory
Newington VA Medical Center
Newington, CT

2002-Present
Medical Director, Pulmonary Rehabilitation
VA Connecticut Healthcare System
West Haven, CT

2010-Present
Medical Director, Yale Clinical COPD Program
Winchester Chest Clinic
Yale-New Haven Hospital
New Haven, CT


UNIVERSITY SERVICES:

1991-Present
Fellowship Selection Committee
Section of Pulmonary and Critical Care

1991-Present
Participant in Yale Affiliated Hospitals Postgraduate Program:
4-8 Sessions/year as invited speaker for Grand Rounds, house staff conferences and/or case discussant on Pulmonary or Critical Care Subspecialty Rounds

1991-Present
Faculty Participant (lecturer, workshop leader) in Second Year
Medical Student Mechanisms of Disease Course: Module on Pulmonary Disease, Yale University School of Medicine

1992-1996
Faculty Advisor for Medical Student Thesis Research (Leigh Miyamoto: “Regulation of CD44 Expression in the human myelomonocytic cell line THP-1 and the pattern of CD44 Expression in human diseases”)

1993-2002
Faculty Participant in Fourth Year Medical Student Ambulatory Care Workshops in Pulmonary Disease

1993-Present
Faculty Speaker, Medical House staff Noon Conferences
(topics: DVT and Pulmonary Embolism, COPD, Pleural Effusions, Acute Respiratory Failure, Mechanical Ventilation, Interstitial Lung Disease, Pulmonary Eosinophilic Syndromes, Respiratory Muscle Diseases)

1994-1995
Medical Director of Community Outreach TB Prevention Program, Yale University School of Medicine

1994-1998
Dean’s Committee on Status of Women in Medicine, Subcommittee to Develop Strategies for Mentorship and Career Tracking

1994-Present
Educational Goals/Curriculum Committee, Internal Medicine
Residency Program, Department of Medicine
Yale University School of Medicine

1994-Present
Lecturer: Yale University School of Medicine, Cell Biology 502a

1995-1997
Elected Member, Medical School Council

1996
Physical Diagnosis Teaching Rounds: Physical Examination of the Chest, Second Year Medical Students, Yale University School of Medicine

1996-1998
Pulmonary Section Representative, Working Group on Resident Electives, Department of Medicine,
Yale University School of Medicine

1996-1999
Medical Student Faculty Advisor—Amy Levin, class of 2000

1996-1999
Faculty Participant, Career Counseling Seminar on “Medicine Subspecialties” for Medical Students

1996-2013
Member, Intern Selection Committee
Department of Medicine
Yale University School of Medicine

1997
Participant, Development of Critical Care Pathways for Management of COPD and Pulmonary Embolus, Yale-New Haven Hospital

1997
Faculty Advisor, Resident Peer Teaching Program (Francis Alcedo)

1997-2000
Faculty Member, Progress Committee, Class of 2000
Yale University School of Medicine

1997-Present
Module Director, Second Year Medical Student Mechanisms of Disease Course: Module on Respiratory Disease,
Yale University School of Medicine

1997- 2005
Member, Pre-clinical Course Curriculum Committee for Medical Students

1997-2003
Faculty Participant, Medical Student Clinical Advisor Program

1997-2003 Participant, Medical Internship/Residency Faculty Mentorship Program

1997-2012
Course Director, Respiratory Physiology and Pathophysiology Module of Physician Associate Training Program, Yale University School of Medicine

1997-Present
Lecturer and Workshop Leader, Respiratory Physiology and Pathophysiology Module of Physician Associate Training Program, Yale University School of Medicine

1997-2001
Member, Physician Associate Program Curriculum Committee

1997-2002
Didactic Series of Lectures for Pulmonary Fellows on Pulmonary Rehabilitation Rotation at Gaylord Hospital or Hospital for Special Care: Topics include: Pathophysiology of COPD, Causes of exercise intolerance in patients with chronic lung disease, Introduction to pulmonary rehabilitation: program structure and components, Clinical outcomes of pulmonary rehabilitation, Mechanisms of improvement in exercise tolerance following pulmonary rehabilitation, Respiratory problems associated with spinal cord injury and neuromuscular disease, Long term oxygen therapy, Management of the patient with a tracheostomy.

1998-2000
Faculty Participant, “Examination of the Muscles”, for Second Year Yale Medical Students, Gaylord Hospital, Wallingford, CT

1998-2002
Faculty Speaker, “Examination of the Chest”, Physician-Patient
Encounter course for First Year Medical Students

2002-2012
Pulmonary Section Coordinator for Yale Affiliated Hospitals Program

2013-Present
Member, Module Review Committee, Second Year Medical Student “Mechanisms of Disease” Course, Yale University School of Medicine


[Publications]
[Articles (peer reviewed manuscripts and reviews)]

1. Bilezikian JP, Gammon DE, Rochester CL, Shand DG, A radioreceptor assay for propranolol, Clin Pharmacol Ther Aug 26 (2) 173-80, 1979.

2. Rochester CL, Gammon DE, Shane E, Bilezikian JP, A radioreceptor assay for
propranolol and 4-hydroxypropranolol, Clin Pharmacol Ther, July 28 (1) 32-9,1980.

3. Rochester CL, Goodell EM, Stoltenborg JK, Bowers WE, Dendritic cells from rat lung are potent accessory cells, Am Rev Respir Dis 138:121-8, 1988.

4. Askenase PW, Herzog WR, Millet I, Paliwal V. Ramabhadran R, Rochester CL,
Geba GP, Ptak W, Serotonin initiation of delayed-type hypersensitivity (DTH):
Mediation by a primitive Thy-1+antigen-specific monoclonal IgE antibody,
Skin Pharmacol 4:25-42, 1991.

5. Rochester CL, Rankin JA, Is asthma T cell-mediated? (Editorial), Am Rev Resp Dis 144 (5) 1005-7, 1991.

6. Rankin JA, Marcy T, Rochester CL, Sussman J, Smith S, Buckley P, Lee D, Human airway macrophages: a technique for their retrieval and a descriptive comparison to alveolar macrophages, Am Rev Resp Dis 145:928-33, 1992.

7. Sampson PM, Rochester CL, Freundlich B, Elias JA, Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production: evidence for cytokine-regulated hyaluronan degradation and human lung fibroblast-derived hyaluronidase, J Clin Invest 90:1492-1503, 1992.

8. Rochester CL, Einarsson O, New directions in therapy for chronic asthma, Clinical Pulmonary Medicine 2:315-26, 1995.

9. Cain, HC, Rochester CL, Corticosteroids for chronic asthma, Contemporary Internal Medicine 7:79-92, 1995.

10. Einarsson, O, Rochester CL, Alternative therapy for asthma, Contemporary Internal Medicine 8:41-50, 1995.

11. Rochester CL, Ackerman, SJ, Zheng T, Elias JA, Eosinophil-fibroblast interactions: granule major basic protein interacts with IL-1 and transforming growth factor-beta in the stimulation of lung fibroblast IL-6 type cytokine production, J Immunol 156:4449-56, 1996.

12. Rochester CL, Anwar MS, Lung volume reduction surgery for emphysema: does it make sense?, Contemporary Internal Medicine, 9(10):25-36, 1997.

13. Rochester CL, Ferranti R, Long-term oxygen therapy for chronic respiratory insufficiency: What role in chronic disease?, J Respir Dis 18 (9) 806-11, 1997.

14. Rochester CL, Ferranti R, Long-term oxygen therapy: What benefits for your patients?, J Respir Dis 19 (2) 133-51, 1998.

15. Rochester CL, Ferranti R, Long-term oxygen therapy: How to prescribe and monitor, J Respir Dis 19 (3) 227-33, 1998.

16. Rochester CL, Ferranti R, Long-term oxygen therapy: Choosing a delivery system, J Respir Dis 19 (8) 673-84, 1998.

17. Lareau S, ZuWallack R, Carlin B, Celli B, Fahy B, Gosselink R, Jones PW, Larson J, Meek P, Rochester CL, Sassi D, Stubbing D, American Thoracic Society Statement on Pulmonary Rehabilitation-1999, Am J Respir Crit Care Med 159 (5) 1666-82, 1999.

18. Sethi JM, Rochester CL, Smoking and chronic obstructive pulmonary disease, (Invited Review), Clin Chest Med 21 (1) 67-86, 2000.

19. Rochester CL, Which pulmonary rehabilitation program is best for your patient?, J Respir Dis 21 (9) 539-46, 2000.

20. Rochester CL, Mechanisms of improvement in exercise tolerance following pulmonary rehabilitation, Clin Pulm Med 7 (6) 287-94, 2000.

21. Rochester CL, Case Records of the Massachusetts General Hospital, “A 47 year old woman with hypogammaglobulinemia, asthma, non-resolving pulmonary infiltrates, and progressive respiratory failure”, New Engl J Med 343 (25) December 21, 2000.

22. Carone M, Ambrosino N, Bertolotti G, Bourbeau J, Cuomo V, DeAngelis G, Gaurit G, Gasparotto A, Giamesio P, Ilowite J, Ioli F, Melchor R, Neri M, Nishimura K, Oliveira LVF, Pierobon A, Ramponi A, Rochester CL, Salajka F, Lauro IS, Singh S, Zaccaria S, Votto J, ZuWallack R, Jones PW, Donner CF, on behalf of the QUESS Group, Quality of life evaluation and survival study: a 3 year prospective multinational study on patients with chronic respiratory failure, Monaldi Arch Chest Dis 56(1)17-22, 2001.
23. Bourjeily G, Rochester CL, Palermo F, Mohsenin V, Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease, Thorax 57(12)1045-9, 2002.

24. Morgan M, Singh S, Rochester C, Why do we need another respiratory journal? (Editorial) Chronic Respir Dis 2004; 1(1)1

25. Rochester CL, Clinical year in review IV: asthma, chronic obstructive pulmonary disease, exercise and rehabilitation, and critical care medicine.
Proc Am Thorac Soc. 2005;2(6):461-5. No abstract available.
PMID: 16352748 [PubMed - indexed for MEDLINE]

26. Reardon J, Casaburi R, Morgan M, Nici L, Rochester C, Pulmonary rehabilitation for COPD, Respir Med 2005; 99:519-27.

27. Nici L, Donner C, Wouters E, ZuWallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O’Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T, American Thoracic Society/ European Respiratory Society Statement on Pulmonary Rehabilitation , Am J Respir Crit Care Med 2006; 173(12)1390-413.

28. Kang M-J, Homer RJ, Gallo A, Lee CG, Crothers K, Cho SJ, Rochester C, Cain H, Chupp G, Yoon HJ, Elias JA, IL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation, J Immunol 2007 Feb 1;178(3):1948-59.

29. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, ZuWallack R, Herrerias C, Pulmonary rehabilitation: Joint ACCP/AACVPR Evidence-based Clinical Practice Guidelines, Chest 2007; 131 (5Suppl):4S-42S.

30. Rochester, CL, “Electrical Stimulation of Peripheral Muscles in COPD: Theory and Practice”, Proceedings of the 5th International Conference on Pulmonary Rehabilitation and Management of Chronic Respiratory Failure, Multidisciplinary Respiratory Medicine 2007; 3:92-7.

31. Rochester, CL, “Inpatient Pulmonary Rehabilitation”, Proceedings of the 5th International Conference on Pulmonary Rehabilitation and Management of Chronic Respiratory Failure, Multidisciplinary Respiratory Medicine 2007:4:71-4.

32. Decramer M, Nici L, Nardini S, Reardon J, Rochester CL, Sanguinetti CM, Troosters T, Targeting the COPD Exacerbation, Respiratory Medicine 2008; 102Suppl 1; S3-15.


33. Rochester, CL, Pulmonary rehabilitation for patients who undergo lung-volume reduction surgery or lung transplantation, Respiratory Care 2008; 53(9)1196-202.

34. Nici L, Raskin J, Rochester CL, Bourbeau JC, Carlin BW, Casaburi R, Celli BR, Cote C, Crouch RH, Diez-Morales LF, Donner CF, Fahy BF, Garvey C, Goldstein R, Lane-Reticker A, Lareau SC, Make B, Maltais F, Mc Cormick J, Morgan MD, Ries A, Troosters T, ZuWallack R, Pulmonary rehabilitation: what we know and what we need to know, J Cardiopulm Rehabil Prev 2009; 29(3)141-51.

35. Dallas M, Haggerty M, McCusker C, Rochester CL, ZuWallack RL, Using pedometers to monitor walking activity in outcome assessment for pulmonary rehabilitation, Chronic Respiratory Disease 2009; 6(4)217-24.

36. Vaz Fragoso CA, Concato J, McAvay G, Van Ness PH, Rochester CL, Yaggi HK, Gill TM, Defining chronic obstructive pulmonary disease in older persons, Respir Med 2009; 103(10)1468-76.

37. Rochester CL, Rehabilitation in the Intensive Care Unit, Seminars in Respiratory and Critical Care Medicine, issue on “Pulmonary Rehabilitation”, 2009; 103(10)1468-76.

38. Vaz Fragoso CA, Concato J, McAvay G, Van Ness PH, Rochester CL, Yaggi HK, Gill TM, The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease, Am J Respir Crit Care Med 2010; 181(5)446-51.

39. Vaz Fragoso CA, Concato J, McAvay G, Van Ness PH, Rochester CL, Yaggi HK, Gill TM, Chronic obstructive pulmonary disease in older persons: a comparison of two spirometric definitions, Respiratory Medicine. 104(8):1189-96, 2010 Aug.

40. Oliva IB, Cortopassi F, Rochester CL, Rubinowitz AN, Combined Pulmonary fibrosis and emphysema syndrome, a radiologic perspective, Monaldi Arch Chest Dis 2011; 75(4) 220-34.

41. Rochester CL, Pulmonary rehabilitation for patients with acute exacerbations of chronic obstructive pulmonary disease, Lung Health Professional (Publication from the COPD Foundation) (non- peer-reviewed invited submission), Fall 2012.

42. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester CL, Hill K, Holland AE, Lareau SC, Man WD-C, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FME, Casaburi R, Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, Troosters T, Janssen DJA, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, Garrod R, Schols AMWJ, Carlin B, Benzo R, Meek P, Morgan M, Rutten-van Molken MP, The Official 2013 American Thoracic Society, European Respiratory Society Statement: Advances in Pulmonary Rehabilitation, Am J Respir Crit Care Med 2013; Oct 15; 188(8)e13-64.

43. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester CL, Hill K, Holland AE, Lareau SC, Man WD-C, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FME, Casaburi R, Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, Troosters T, Janssen DJA, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, Garrod R, Schols AMWJ, Carlin B, Benzo R, Meek P, Morgan M, Rutten-van Molken MP, Key Concepts and Advances in Pulmonary Rehabilitation, Based on the Official 2013 American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation (Executive Summary), Am J Respir Crit Care Med 2013: 188(8)1011-27.

44. Possick J, Most J, Rochester CL, Advances in the outpatient management of chronic obstructive pulmonary disease, Clinical Pulmonary Medicine 2013; 20(6)259-70.

45. Rochester CL, Maltais F, Invited Editorial: “Innovate to ambulate: creating opportunities for patients with chronic obstructive pulmonary disease”, Am J Respir Crit Care Med 2013;188:265-6.

46. Franssen F, Rochester CL, Comorbidities in patients with COPD and pulmonary rehabilitation: do they matter? Eur Respir Rev 2014; 1;23(131)131-41.

47. Rochester CL, Spanevello A, Invited Editorial, Heterogeneity of Pulmonary Rehabilitation: Like Apples and Oranges—Both healthy Fruit, Eur Respir J, Online DOI: 10.1183/09031936.00021114, May 2014.

48. Most JF, Possick J, Rochester CL, Medical comorbidities associated with chronic obstructive pulmonary disease, Invited Review, Clinical Pulmonary Medicine 2014; 21(4)155-66.

49. Watz H, Pitta F, Rochester CL et al., An Official European Respiratory Society statement on physical activity in COPD, Eur Respir J 2014; 44:1521-37.

50. Rochester CL, Vogiatzis I, Holland AE et al., American Thoracic Society/European Respiratory Society Official Policy Statement on Pulmonary Rehabilitation, Am J Respir Crit Care Med, Submitted, revisions in progress June 2015

51. Rochester CL, Holland AE, Pulmonary rehabilitation for non-COPD Respiratory Disorders, Invited Concise Clinical Review, Am J Respir Crit Care Med, in Preparation for submission, June 2015

[Chapters]

1. Rochester CL, Elias JA, Cytokines and cytokine networking in the pathogenesis of interstitial and fibrotic lung disorders, Seminars in Resp Med 14 (5) 389-416, 1993.

2. Einarsson O, Rochester CL, Rosenbaum S, Airway management in respiratory emergencies, Clin Chest Med 15 (1) 13-34, 1994.

3. Rochester CL, Chapter 74: The Eosinophilic Pneumonias, in Pulmonary Diseases and Disorders, Alfred P. Fishman, Ed, Third Edition, McGraw Hill, New York, NY, p1133-50, 1997.

4. Rochester CL, Mohsenin V, Respiratory Complications of Stroke, Semin Resp Med Crit Care Med, 23(3)248-60, 2002.

5. Bourjeily G, Rochester CL, Exercise training in chronic obstructive pulmonary disease, Clin Chest Med 2000;21(4)763-81.

6. Rochester CL, Exercise training in chronic obstructive pulmonary disease, J Rehabil Research and Devel, 2003;40(5) Supplement 2:59-80.

7. Sharma G, Rochester CL, Respiratory disorders associated with obesity, Invited Review for Pulmonary and Critical Care Update Online, American College of Chest Physicians On Line Journal, Fall 2004.

8. Rochester CL, Disease-specific approaches in pulmonary rehabilitation, In: AACVPR Guidelines for Pulmonary Rehabilitation Programs, Human Kinetics, Summer 2004.

9. Crothers K and Rochester, CL, The Eosinophilic Pneumonias, in Pulmonary Diseases and Disorders, Alfred P. Fishman, Elias JA, Grippi MA, Kaiser LR, Senior RM Eds, Fourth Edition, McGraw Hill, New York, NY, 2008; p 1213-32.

10. Chupp G and Rochester CL, Allergic Bronchopulmonary Aspergillosis, in Pulmonary Diseases and Disorders, Alfred P. Fishman, Elias JA, Grippi MA, Kaiser LR, Senior RM Eds, Fourth Edition, McGraw Hill, New York, NY, 2008; p 837-44.

11. Rochester CL, Innovative approaches in muscle training: Transcutaneous electrical muscle stimulation, in: Novel Approaches to Rehabilitation for the Patient with Chronic Respiratory Failure, Goldstein RS and Ambrosino NL, eds., Fall 2008.

12. Rochester CL, Pulmonary rehabilitation for disorders other than COPD, in: Pulmonary Rehabilitation: Guidelines for Success, Fourth Edition, Hodgkin JE, Celli B, Connors GA, Eds, Mosby Inc. Fall 2008.

13. Rochester CL, Disease-specific approaches in pulmonary rehabilitation, In: AACVPR Guidelines for Pulmonary Rehabilitation Programs, Human Kinetics, 2010

14. Martinello RA, Rochester CL, Acute COPD Exacerbation, BMJ Point of Care (On line publication; powered by EPOCRATES), Updated annually, most recently in December 2014 http://online.epocrates.com/u/29118/Acute+COPD+exacerbation

15. Teba C, Rochester CL, Allergic Bronchopulmonary Aspergillosis, , In Clinical Decision Support: Pulmonary Medicine and Sleep Disorders, edited by Grippi MA, Heffner J, Kotloff R, 2013. Decision Support in Medicine, LLC. Wilmington, DE (On-line Publication)

16. Rochester CL, Cain H, Chronic Obstructive Pulmonary Disease, Baliga R, Ed., American Board of Internal Medicine Board Review Book, In Press, summer 2014

17. Rochester, CL, The Eosinophilic Pneumonias, in Pulmonary Diseases and Disorders, Alfred P. Fishman, Elias JA, Grippi MA, Kaiser LR, Senior RM Eds, Fifth Edition, McGraw Hill, New York, NY, 2014.

18. Rochester CL, Fairburn C, Crouch RH, Pulmonary rehabilitation for respiratory disorders other than chronic obstructive pulmonary disease, Clinics In Chest Medicine 2014; 35(2)369-89.

19. Vaz Fragoso CA, Akgun KM, Jeffery SM, Kapo JM, Possick JD, Rochester CL, Lee PJ, Chronic Obstructive Pulmonary Disease, In: Hazzards Geriatric Medicine and Gerontology, 7th Edition, McGraw Hill, In Press, June 2015

20. Most JF, Rochester CL, Chronic Obstructive Lung Disease in the Elderly,
Submitted for inclusion in: The Aging Lung: Mechanisms and Clinical Sequelae, Lung Aging Monograph, World Scientific Press 2015


[Abstracts]

1. Rochester CL, Elias JA, Olchowski J, Rankin JA, Lipopolysaccharide (LPS) induces neutrophil attractant activation protein-1/Interleukin 8 (NAP-1/IL-8) release from the THP-1 human monocyte cell line, Am Rev Respir Dis 145 (4) A236, 1992.

2. Rochester CL, Ray P, Whiting N, Goldsmith K, Elias JA, Cytokine regulation of human lung fibroblast hyaluronic acid receptor (CD44) gene expression, Am Rev Respir Dis 145 (4) A667, 1992.

3. Rochester CL, Ackerman SJ, Redlich C, Rankin JA, Elias JA, Eosinophil major basic protein enhances cytokine production by Interleukin-1 stimulated human lung fibroblasts, Am Rev Respir Dis 147 (4) A733, 1993.

4. Rochester CL, Longley J, Homer R, Elias JA, Expression of CD44 protein in sarcoidosis, tuberculosis and other granulomatous disorders, Am Rev Respir Dis 147 (4) A789, 1993.

5. Rochester CL, Ackerman SJ, Zheng T, Elias JA, Major basic protein regulation of cytokine production by human lung fibroblasts, Am J Respir Crit Care Med 149 (4) A13, 1994.

6. Rochester CL, Ackerman SJ, Zheng T, Rankin JA, Elias JA, Major basic protein regulation of lung fibroblast cytokine production: role of cytokine synergy and charge, Chest 107 (3S) S117-8, 1995.

7. Redlich C, Rochester CL, Smith B, Wirth J, Homer R, Askenase PW, Karol M, Sparer J, Cullen M, Immunologic responses to isocyanates in sensitized asthmatic subjects, Selected for oral presentation, 38th Annual Aspen Lung Conference, Aspen, CO, June 1995, Chest 109 (3) 6S-8S, 1996.

8. Cain, HC, Rochester CL, Franco K, Gee JBL, Mohsenin V. One year survival after lung volume reduction surgery compared to inpatient pulmonary rehabilitation for severe COPD, Am J Respir Crit Care Med 155 (4) A607, 1997.

9. Carone M, Donner CF, Jones PW on behalf of the QUESS Group, The Quality of Life Evaluation and Survival Study (QUESS): One year follow-up from a multinational study to evaluate impaired health and natural history of chronic respiratory failure, Am J Respir Crit Care Med; 159 (3) A312, 1999.

10. Whittaker LA, Brodeur LE, Rochester CL, Functional outcome of inpatient pulmonary rehabilitation for patients with morbid obesity, Am J Respir Crit Care Med; 161 (3) A495, 2000.

11. Bourjeily G, Palermo F, Rochester CL and Mohsenin V, Transcutaneous stimulation of the lower extremities improves muscle mass, strength, and exercise endurance in severe chronic obstructive pulmonary disease (COPD), Am J Respir Crit Care Med, April 2001.

12. Gerstenhaber B, Twohig E, Rochester CL, Physician knowledge regarding pulmonary rehabilitation referral and outcomes, American Thoracic Society Meeting, New Orleans, LA, 2010, A1207.

13. Gerstenhaber B, Rosenblum D, Kowalsky D, Palermo F, Rochester CL, Costigan-Humes C, Tall L, Electrical stimulation of accessory muscles of respiration: is there a role for enhancing weaning from mechanical ventilator support in long term acute care? Am J Respir Crit Care Med 2012; 185: A3901. Annual Meeting, American Thoracic Society, San Francisco CA, May 2012

14. Most JF, Qin L, Dallas MI, Rochester CL. Poster for Abstract 5124: Medical comorbidities among patients with chronic obstructive pulmonary disease referred for outpatient pulmonary rehabilitation at VA Connecticut Healthcare System (VACHS); Poster Discussion Session “Pulmonary rehabilitation organization and outcomes”, Annual American Thoracic Society International Meeting, Philadelphia, PA, May 2013.

15. Most JF, Qin L, Dallas MI, Rochester CL. Poster for Abstract 5125: “The impact of medical co-morbidities on outcomes of pulmonary rehabilitation for patients with chronic obstructive pulmonary disease (COPD)”; Poster Discussion Session “Pulmonary rehabilitation organization and outcomes”, Annual American Thoracic Society International Meeting, Philadelphia, PA, May 2013.

16. DuVall SL, Brown KA, Nici L, Rochester CL, Nechodom P, Fox KM, Chun D, Viernes B, DiPietro M, Incidence and predictors of hospital readmission among patients with chronic obstructive pulmonary disease in the department of Veterans Affairs, Submitted to American College of Chest Physicians Annual Meeting 2015

17. Masefield S, Rochester CL, Vogiatzis I, Patients’ perspectives on challenges to pulmonary rehabilitation participation: an international web-based survey, Submitted to European Respiratory Society Annual Meeting, Amsterdam, The Netherlands, 2015


[Awards/Honors]
1982-Present
Alpha Omega Alpha Society

1983
American Medical Women’s Association Achievement Citation

1986-1988
Research Fellowship in Pulmonary Diseases
NIH Training Grant # 5T32HL 07018-13 0031

1990-1992
Research Fellowship Training Grant
American Lung Association of Connecticut

1992-1997
NIH Clinical Investigator Award #HLO2687

1996-1997
Co-investigator, Project Title: T Cells in the Pathogenesis of Human Isocyanate Asthma
NIH Pulmonary SCOR Grant

1998-2001
Regional Principal Investigator, “Quality of Life and Survival of Patients Affected by Chronic Respiratory Failure”, Gaylord Hospital Research Institute, Wallingford, CT

2002-2012 Listed as one of “New York Metro Area’s Best Doctors” in Pulmonary Disease, New York Magazine

2002-2009
Local Principal Investigator, “ UPLIFT Trial” a Multinational, Multi-center 4 year Clinical Trial Sponsored by Boehringer Ingelheim Pharmaceuticals
Research Conducted at West Haven VA Medical Center, West Haven, CT

2006-2014
Local Principal Investigator, “ECLIPSE Trial”, a Multicenter, Multinational 3 year Clinical Trial Sponsored by Glaxo-Smith Kline Pharmaceuticals
Research Conducted at Yale University School of Medicine

2008
Invited participant, NIH Study Section, SPIROMICS Study of COPD

2008-2012
Recipient, VA Merit Review Grant, Rehabilitation Research and Development Division, Title ”Rehabilitation of Patients with COPD Using Electrical Muscle Stimulation”, Ongoing at VA Connecticut Healthcare System, West Haven Campus